Dr. Michael E. Blam, MD

Dr. Blam practices at Gastro-Digestive Medical Group in Lynwood, California.

Dr. Blam's NPI, 1801877733, was assigned on November 8, 2005. Dr. Blam graduated from Washington University in St. Louis School of Medicine in 1995. Dr. Blam's Connecticut license number on file is 039355.

Dr. Blam's primary practice is Gastro-Digestive Medical Group, at 3621 Martin Luther King Jr Blvd, Lynwood, CA 90262 in Los Angeles County. The practice phone is (562) 862-3656.

Dr. Blam's primary practice is Gastro-Digestive Medical Group in Lynwood, California. Dr. Blam is also affiliated with St. Francis Medical Center. The medical group on file is Gastro Digestive Medical Group. Dmand AI also links Dr. Blam to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blam practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Blam's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Blam is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Blam's licenses on file in 4 states: Connecticut, California, Pennsylvania and New York.

Dmand AI lists acid reflux, colonoscopy, gastrointestinal bleeding, hepatitis c and upper GI endoscopy among the conditions Dr. Blam treats.

CMS data shows 1,787 Medicare services from Dr. Blam across 10 procedure codes in 2024, for 558 Medicare patients. Medicare paid $141,635 for them.

CMS counts 558 Medicare patients who saw Dr. Blam in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 88% are also on Medicaid. Their average risk score is 4.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blam's median patient age at 66, with 51% women.

In 2024, Dr. Blam wrote 785 Medicare Part D claims for 440 patients. 78% of them were for generic drugs. CMS names the drug for 708 of them, across 15 drugs with 11 or more claims each, at $66,189 in total drug cost. In 2023, CMS named 794 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Blam for performance year 2024, reported as part of a group. CMS counts 178 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Blam, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Blam. The most frequent topics are Diagnosis, Differential. Dr. Blam has published most often in Am J Gastroenterol. Dr. Blam's most frequent co-author is David A. Katzka, MD.

CMS Open Payments shows 136 general payments to Dr. Blam from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bausch Health Americas, Inc. paid the most, $1,319.

Dmand AI lists 1 award for Dr. Blam, most recently CMS Stage 1 EHR in 2013.

Dr. Blam graduated from Washington University in St. Louis School of Medicine in 1995.

Dr. Blam is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.